• Arts, H.J., Hollema, H., Lemstra, W., Willemse, P.H., De Vries, E.G., Kampingga, H.H. and Van der Zee, A.G., Heat-shock-protein-27 (HSP27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis. Int. J. Cancer, 84, 234-238 (1999).
  • Buchner, J., Hsp90 & co.: a holding for folding. Trends Biochem. Sci., 24, 136-141 (1999).
  • Ciocca, D.R., Clark, G.M., Tandon, A.K., Fuqua, S.A., Welch, W.J. and McGuire, W.L., Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J. nat. Cancer Inst., 85, 570-574 (1993).
  • Conroy, S.E., Gibson, S.L., Brunstrom, G., Isenber, G.D., Luqmani, Y. and Latchman, D.S., Autoantibodies to 90 kD heat-shock protein in sera of breast cancer patients. Lancet, 345, 126 (1995).
  • Conroy, S.E. and Latchman, D.S., Do heat shock proteins have a role in breast cancer? Brit. J. Cancer, 74, 717-721 (1996).
  • Conroy, S.E., Sasieni, P.D., Amin, V., Wang, D.Y., Smith, P., Fentiman, I.S. and Latchman, D.S., Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer. Brit. J. Cancer, 77, 1875-1879 (1998).
  • Ferrarini, M., Heltai, S., Zocchi, M.R. and Rugarli, C., Unusual expression and localization of heat-shock proteins in human tumor cells. Int. J. Cancer, 51, 613-619 (1992).
  • Fujiwara, K., Shirafuji, H., Fushitani, K., Fujimoto, K., Kohno, I. and Modest, E.J., Change in the localization of heat shock protein 27 (HSP27) in BG-1 human ovarian cancer cells following treatment by the ether lipid ET-18-OCH3. Anticancer Res., 19, 181-187 (1999).
  • Garrido, C., Ottavi, P., Froomentin, A., Hamman, A., Arrigo, A.P., Chauffert, B. and Mehlen, P., Hsp27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res., 57, 2661-2667 (1997).
  • Geisler, J.P., Geisler, H.E., Tammela,J., Wiemann, M.C., Zhou, Z., Miller, G.A. and Crabtree, W., Heat shock protein 27: an independent prognostic indicator of survival in patients with epithelial ovarian carcinoma. Gynecol. Oncol., 69, 14-16 (1998).
  • Jeremias, J., David, S.S., Toth, M. and Witkin, S.S., Induction of messenger RNA for the 70 kDa heat shock protein in HeLa cells and the human endocervix following exposure to semen: implications for antisperm antibody production and susceptibility to sexually transmitted diseases. Hum. Reprod., 12, 1915-1919 (1997).
  • Langdon, S.P., Rabiasz, G.J., Hirst, G.L., King, R.J., Hawkins, R.A., Smyth, J.F. and Miller, W.R., Expression of the heat-shock protein hsp27 in human ovarian cancer. Clin. Cancer Res., 1, 1603-1609 (1995).
  • Lebeau, J., Le chalony, C., Prosperi, M.T. and Goubin, G., Constitutive overexpression of a 89-kDa heat shock protein gene in the HBL 100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene. Oncogene, 6, 1125-1132 (1991).
  • Lemieux, P., Oesterreich, S., Lawrence, J.A., Steeg, P.S., Hilsenbeck, S.G., Harvey, J.M. and Fuqua, S.A., The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells. Invas. Metastas., 17, 113-123 (1997).
  • Love, S. and King, R.J., A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Brit. J. Cancer, 69, 743-748 (1994).
  • Mehlen, P., Mehlen, A., Guillet, D., Preville, X. and Arrigo, A.P., Tumor necrosis factor-α induces changes in the phosphorylation, cellular localization, and oligomerization of human hsp27, a stress protein that confers cellular resistance to this cytokine. J. cell. Biochem. 58, 248-259 (1995).
  • Nambu, K., Konshi, I., Komatsu, T., Mandai, M., Yamamoto, S., Kuroda, H., Koshiyama, M. and Mori, T., Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Cancer, 77, 330-338 (1996).
  • Padwick, M.L., Whitehead, M. and King, R.J., Hormonal regulation of hsp27 expression in human endometrial epithelial and stromal cells. Molec. Cell Endocrinol., 102, 9-14 (1994).
  • Udono, H. and Srivastava, P., Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70. J. Immunol., 152, 5398-5403 (1994).
  • Vargas-Roig, L.M., Gago, F.E., Tello, O., Aznar, J.C. and Ciocca, D.R., Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int. J. Cancer, 79, 468-475 (1998).
  • Yufu, Y., Nishimura, J. and Nawata, H., High constitutive expression of heat shock protein 90α in human acute leukemia cells. Leuk. Res., 16, 597-605 (1992).